Legal Features

Articles

Part 26A restructuring plans – where are we now for the restructuring tool of choice?

Michael Mulligan, Charlotte Mullis, and Martha Wyrick from Haynes and Boone, discuss the lessons learned from numerous rulings by English courts in 2024 on restructuring plan decisions

Reflections on Judging

On 30 September 2024 Sir Jonathan Cohen KC retired from being a full-time High Court Judge of the Family Division

The UK Arbitration Bill: what do you need to know?

Ashleigh Brocchieri, Expert Counsel, and Colleen Parker-Bacquet, Counsel, for the ICC International Court of Arbitration, provide an overview of the UK’s Arbitration Bill

A missed opportunity to make health, education and social support savings through investment in early justice interventions

Associate Professor Liz Curran, Nottingham Law School, explains how justice expenditure could be redirected for better social outcomes

The US Corporate Transparency Act: a guide for non-US lawyers

Gregory Herman-Giddens, Attorney at Law at TrustCounsel, offers guidance for non-US lawyers on the Corporate Transparency Act, with a focus on the unique challenges and issues related to entities held in trust

Stand-off from Standish: where now for the reform of English financial divorce law

With proposals for reform due from the Law Commission, Andrew Barton, a Partner at Stephens Scown LLP, asks whether a recent Court of Appeal decision is likely to lead to greater predictability in the law or an increased likelihood of statutory reform

Non-competition agreements: an ongoing and heated dispute in US law

Geoffrey A. Mort, Of Counsel at Kraus & Zuchlewski LLP, New York, provides a detailed overview of the debate surrounding non-compete agreements in the US and the issues related to their continued and future use

Is the UK’s life sciences regulator, the MHRA, creating the right conditions to encourage businesses investing in artificial intelligence products?

Peter Rudd-Clarke, a Partner in Osborne Clarke’s life sciences and healthcare team, Tamara Quinn, a Director in Osborne Clarke’s AI, data and IP knowledge team, and Julia Smith, an associate in Osborne Clarke’s commercial team, provide a detailed breakdown of the approach being taken to artificial intelligence within the life sciences sector and the upcoming regulatory developments